Ribosomal protein L31 pseudogene 10 (RPL31P10)

RPL31P10 is a processed pseudogene derived from the ribosomal protein L31 gene, encoded in the human genome[2][5]. Pseudogenes are nonfunctional, noncoding copies of genomic DNA that arise from retrotransposition or gene duplication events[8]. RPL31P10 does not encode a functional protein, and there is no evidence suggesting it plays a biological or pathological role. The canonical ribosomal protein L31 is part of the 60S ribosomal subunit and contributes to protein synthesis[1][7]. However, pseudogenes like RPL31P10 do not have enzymatic, receptor, transporter, or signaling functions—they are generally not utilized as biomarkers, therapeutic drug targets, or associated with safety concerns. There is nothing inherently misspelled or malformed about "RPL31P10"—it is the formal designation for the tenth pseudogene related to RPL31, correctly identified as a pseudogene[2][11]. Its functional parent, ribosomal protein L31, is a bona fide protein-coding gene with associated biological and disease relevance[7], but this relevance does not transfer to its pseudogenes such as RPL31P10[8]. Pseudogenes can sometimes be transcribed, but there is no evidence for disease association or drug targeting for RPL31P10. Essential facts for downstream informatics: RPL31P10 is not a receptor, enzyme, transporter, or functional protein-coding gene. It is not a therapeutic target and should not be considered for pharmacological annotation or drug interaction mapping. Any disease or biomarker-related associations apply only to the canonical ribosomal protein L31 (RPL31), not to processed pseudogenes like RPL31P10. If you require information on the functional ribosomal protein, refer to "60S ribosomal protein L31" (gene symbol: RPL31)[1][7].

Other names

RPL31_15_1198RPL31P10